Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.67 EUR | +0.75% | -2.20% | +11.25% |
Apr. 05 | Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors | CI |
Mar. 22 | Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition | MT |
Sales 2023 | 3.91M 4.18M | Sales 2024 * | 5.9M 6.31M | Capitalization | 54.3M 58.06M |
---|---|---|---|---|---|
Net income 2023 | -3M -3.21M | Net income 2024 * | -3M -3.21M | EV / Sales 2023 | 13.9 x |
Net cash position 2023 * | 5.8M 6.2M | Net cash position 2024 * | 1.6M 1.71M | EV / Sales 2024 * | 8.93 x |
P/E ratio 2023 |
-14.1
x | P/E ratio 2024 * |
-17.8
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 65.43% |
1 day | +0.75% | ||
1 week | -2.20% | ||
Current month | -1.11% | ||
1 month | +2.69% | ||
3 months | +13.62% | ||
6 months | +13.62% | ||
Current year | +11.25% |
Managers | Title | Age | Since |
---|---|---|---|
Timo Lehtonen
CEO | Chief Executive Officer | 49 | 19-02-28 |
Director of Finance/CFO | 57 | 21-01-31 | |
Chairman | 53 | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 53 | 16-04-30 | |
Director/Board Member | 50 | 19-12-31 | |
Director/Board Member | 65 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.67 | +0.75% | 8,190 |
24-04-25 | 2.65 | -1.85% | 6,777 |
24-04-24 | 2.7 | -1.82% | 13,858 |
24-04-23 | 2.75 | -0.36% | 12,166 |
24-04-22 | 2.76 | +1.10% | 17,984 |
Delayed Quote Nasdaq Helsinki, April 26, 2024 at 10:51 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.25% | 57.97M | |
+73.17% | 12.38B | |
-18.74% | 7.92B | |
+16.15% | 7.2B | |
+4.81% | 5.84B | |
+5.99% | 5.07B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-40.82% | 2.23B | |
+1.49% | 2.02B |
- Stock Market
- Equities
- BRETEC Stock